Serum adenosine deaminase (ADA), 5'nucleotidase (5'NT) and malondialdehyde (MDA) were estimated in patients with acute infective hepatitis (AIH) along with the routine parameters of liver disease.Present study is done to evaluate these special parameters in patients with clinical history of AIH and to assess the utility of these parameters as diagnostic/ prognostic indices of liver function and to correlate special parameters with routine liver function tests (LFT). ADA, 5'NT and MDA along with routine LFT was estimated in 25 patients with AIH and 25 samples from healthy voluntary blood donars served as the control group. Routine LFT was estimated by standard clinical chemistry procedures on dade behring analyser and ADA, 5'NT and MDA were estimated by berthlot reaction, fiske and subbarao method and thiobarbituric acid method respectively.
INTRODUCTION
Liver is perhaps the most biochemically complex organ within the body. It possesses enzymes and cofactors necessary for an unparelled number of metabolic reactions. It is of vital importance in intermediary metabolism and in the detoxification and elimination of toxic substances. Damage to the organ may not obviously affect its activity since the liver has considerable functional reserve and as a consequence, simple tests of liver function like serum bilirubin and albumin concentrations are insensitive indicators of liver disease. The results of biochemical tests are frequently non specific, since they reflect the basic pathological processes common to many conditions, they therefore provide limited diagnostic information. Hence tests reflecting
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liver cell damage particularly the measurement of the activities of hepatic enzymes in serum or plasma are often superior in this respect.
Main aim of this study is to evaluate certain parameters in patients with clinical history of infective hepatitis and the objective is to asses the utility of these parameters as diagnostic or prognostic indices of liver function and to correlate between these parameters and routine LFT.
ADA [EC 3.5.4.4] is an enzyme that catalyses the hydrolytic cleavage of adenosine to inosine and ammonia. It is widely distributed in human tissues, highest being in the lymphoid tissue. This enzyme is considered as an ecto-enzyme (1) since it is found on the surface of many cells.
5' NT [EC 3.1.3.5] is a phosphatase that specifically catalyses hydrolysis of nucleotides such as 5' AMP and 5' IMP. In liver, the enzyme is located primarily in the canaliculi and sinusoidal membranes. Serum values of this enzyme is known to be elevated primarily in hepatobiliary diseases (2) (3) (4) (5) .
MDA is an end product of lipid peroxidation (6) . Reactive oxygen species are important mediators of host defense and tissue damage (7, 8) . They are produced in conditions characterized by oxidative stress and they initiate the lipid peroxidation of polyunsaturated fatty acids [PUFA] of the membranes. Hence the determination of lipid peroxide products like MDA, has been used as a measure of oxygen radical activation.
MATERIALS AND METHODS
Serum ADA, 5'NT and MDA were estimated in patients with AIH. Study was conducted on blood samples of the patients sent for investigation to diagnostic clinical laboratory at M S Ramaiah medical teaching hospital. Healthy voluntary blood donars (HVBD) attending the blood bank of our hospital served as the control group.25 venous samples from patients with AIH and 25 samples collected from HVBD which served as the control group, out of which 13 males and 12 were females for both the groups, were analysed for routine Liver function tests(LFT) which included, total and direct bilirubin, total proteins, albumin, aspartate transaminase (AST), alanine transaminase (ALI-) and alkaline phosphatase (ALP) and special investigations like ADA, 5'NT and MDA.
Inclusion criteria -patient population included adults aged from 20 to 50 years, patients clinically diagnosed as having AIH due to hepatitis A, with total bilirubin levels more than 1.2 mg/ dl were selected for the study.
Exclusion criteria -patients with other diseases such as diabetes mellitus, cardiovascular diseases, hypertension ,kidney disease were excluded from the study Data collection -Data of the patients was collected from case files, from medical records section of our hospital.
Sample collection -venous samples received at clinical chemistry laboratory, of our hospital, were allowed to clot and then centrifuged to get the serum, which was then immediately analysed for routine LFT and special investigations like ADA, 5' NT and MDA.
Routine LFT was analysed by standard clinical chemistry procedures on dade behring analyser. Quality control samples from biorad would be run on daily basis on dade behring analyser to check the accuracy and precision of these tests.
The assay of ADA was based on its hydrolytic action on adenosine, the ammonia formed being measured by the berthelot reaction. The substrate used was 0.675 mM adenosine in 0.2 M phosphate buffer at a pH of 7.05. After incubation at 37~ for one hour, the ammonia liberated was estimated by measuring the blue colour produced with the phenol-hypochlorite reagent at 640 nm, in a spectrophotometer (9, 10).
5' NT was estimated using 5' AMP as the substrate and the Pi liberated was determined by the Fiske and Subbarow method (11) . The enzyme was assayed by incubating serum with 10mM 5'AMP in 40 mM barbiturate buffer at pH 7.5. The inhibitory effect of Nickel chloride 0.1 M, on 5' NT was used to differentiate between the total activity and the non-specific alkaline phosphatase activity.
For the determination of serum MDA , the sample was heated with 0.67 % thiobarbituric acid, in the presence of 40% trichloroacetic acid and the amount of pink coloured MDA-TBA adduct produced, was measured at 530 nm in a spectrophotometer (12) .
Statistical analysis was done using students-t test, correlation coefficient was determined between routine LFT and special investigations. Table 1 gives a comparison between the patients and controls for the routine tests of liver function. Patients with liver disease showed significantly higher levels of serum bilirubin and enzymes, as compared with the control group (p < 0.001). It is to be noted that the serum total bilirubin values in the patient group ranged from 1.0 mg % to 25.7 mg % and the direct bilirubin from 0.4 to 11.58 mg %. This wide scatter of values is typical of a pathological condition. The same is true for the enzymatic parameters namely AST and ALT. The S.D for these parameters was therefore higher than the mean. Table 2 gives a comparison between patients and controls, for ADA, 5'NT and MDA. All the three parameters were found to be significantly higher in the patient group (p< 0.001). Table 3 gives correlation between serum bilirubin and serum MDA which shows a significant positive correlation between the two. Table 4 gives correlation between serum total bilirubin and serum ADA in patients with AIH wherein the correlation is statisically significant. (25) correlation coefficient r= 0.45 for r value of 0.4227, p value is < 0.05 for r value of 0.4921, p value is < 0.02 therefore r value of 0.45, p value is <0.05 hence correlation of ADA with bilirubin is statistically significant
RESULTS

DISCUSSION
Increased serum MDA levels indicate that lipid peroxidation processes occur in liver diseases
The first phase in infective hepatitis is the entry of the virus into the parenchymal cells of liver.This is followed by an immune response of the host cell and infiltration of the infected host cell by leucocytes. Free radicals are released by activated leucocytes which cause peroxidation of membrane lipids. There is a rupture of the lysosomal membranes, the release of lysosomal enzymes , necrosis of the cell and destruction of parenchymal tissue. All these processes culminate in an increase in serum MDA levels. Hence, increased serum MDA could be used as a marker for the free radical mediated destruction of liver parenchymal cells.
Consequences of lipid peroxidation
Lipid peroxidation is followed by loss of structural integrity of plasma membranes. As a result, there occurs a release of membrane-associated enzymes like ADA and 5' NT into the circulation. This is seen as a steep rise in the plasma levels of these enzymes~ the assay of which aids in diagnosis. What is of graver significance however, is that, as a sequel to the release of cytosolic contents into the circulation, there occurs a depletion of cellular enzymes, cofactors, metabolites etc. Several crucial homeostatic and protective mechanisms of the cell could be affected. The cell loses its viability and has to be degraded.
Bilirubin as an anti-oxidant
Estimation of serum Bilirubin is routinely carded out in patients with liver disease as a diagnostic or prognostic index. Recent studies have shown that bilirubin should not be considered as just a metabolic waste product. It functions in-vivo as a powerful anti-oxidant, anti-mutagen, anti-complement and an endogenous tissue protector (13) .
Increased serum Bilirubin levels could be looked upon as a compensatory / retaliatory phenomenon in response to cellular peroxidative changes. The finding of a significant positive correlation between serum MDA and serum bilirubin seems to support this hypothesis.
CONCLUSION
Liver disease is accompanied by an increased production of free radicals. Hepatocyte membranes are rich in PUFA, which are susceptible to attack by free radicals. The PUFA of the membranes undergo peroxidation. There is a release of membrane bound enzymes like ADA and 5' NT into the circulation.There is also a rise in serum MDA.The parameters studied therefore serve to indicate that liver diseases are accompanied by lipid peroxidation. Hence these tests would be more sensitive to diagnose the patients with AIH in the initial stages when routine LFT is within normal ranges.
